ICICI Prudential Asset Management Co Ltd lifted its stake in Synopsys, Inc. (NASDAQ:SNPS – Get Rating) by 17.0% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 440 shares of the semiconductor company’s stock after acquiring an additional 64 shares during the quarter. ICICI Prudential Asset Management Co Ltd’s holdings in Synopsys were worth $146,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. Curi Wealth Management LLC acquired a new position in shares of Synopsys in the fourth quarter worth about $26,000. Confluence Wealth Services Inc. acquired a new position in shares of Synopsys in the fourth quarter worth about $31,000. Industrial Alliance Investment Management Inc. acquired a new position in shares of Synopsys in the fourth quarter worth about $36,000. Geneos Wealth Management Inc. lifted its stake in shares of Synopsys by 105.7% in the fourth quarter. Geneos Wealth Management Inc. now owns 109 shares of the semiconductor company’s stock worth $40,000 after acquiring an additional 56 shares in the last quarter. Finally, MCF Advisors LLC acquired a new position in shares of Synopsys in the first quarter worth about $40,000. Hedge funds and other institutional investors own 84.71% of the company’s stock.
Analyst Ratings Changes
Several research analysts recently commented on the company. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $325.00 to $360.00 in a research note on Wednesday, June 29th. UBS Group cut their price objective on Synopsys to $360.00 and set a “hold” rating on the stock in a research note on Thursday, May 19th. Needham & Company LLC upped their price objective on Synopsys from $370.00 to $380.00 and gave the company a “buy” rating in a research note on Thursday, May 19th. Wells Fargo & Company cut their price objective on Synopsys from $415.00 to $375.00 and set an “overweight” rating on the stock in a research note on Thursday, May 19th. Finally, StockNews.com cut Synopsys from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, May 3rd. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $381.70.
Insider Buying and Selling at Synopsys
Synopsys Trading Up 0.5 %
Shares of Synopsys stock opened at $374.29 on Friday. Synopsys, Inc. has a twelve month low of $255.02 and a twelve month high of $377.60. The stock has a market capitalization of $57.26 billion, a price-to-earnings ratio of 58.21, a PEG ratio of 3.02 and a beta of 1.22. The business’s 50 day simple moving average is $322.02 and its 200-day simple moving average is $309.19.
Synopsys (NASDAQ:SNPS – Get Rating) last issued its quarterly earnings data on Wednesday, May 18th. The semiconductor company reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.80 by $0.09. Synopsys had a return on equity of 18.23% and a net margin of 21.19%. The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.25 billion. During the same period in the prior year, the company posted $1.24 EPS. Sell-side analysts predict that Synopsys, Inc. will post 6.29 earnings per share for the current year.
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
- Get a free copy of the StockNews.com research report on Synopsys (SNPS)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.